Alleles in four loci linked to reproductive subtype, in one locus linked to metabolic subtype of PCOS
TUESDAY, June 23, 2020 (HealthDay News) — Distinct subtypes of polycystic ovary syndrome (PCOS) with novel genetic associations have been identified, according to a study published online June 23 in PLOS Medicine.
Matthew Dapas, Ph.D., from the Northwestern University Feinberg School of Medicine in Chicago, and colleagues examined whether there are biologically relevant subtypes of PCOS in a cluster analysis performed in a genotyped cohort of 893 PCOS cases. The clusters were replicated in an independent, ungenotyped cohort of 263 PCOS cases.
The researchers identified two distinct PCOS subtypes in the clustering: a reproductive group (21 to 23 percent), which was characterized by high luteinizing hormone (LH) and sex hormone binding globulin (SHBG) levels with relatively low body mass index (BMI) and insulin levels; and a metabolic group (37 to 39 percent), which was characterized by lower SHBG and LH levels and higher BMI, glucose, and insulin levels. In a genome-wide association study, alleles were identified in four loci that were significantly associated with the reproductive subtype and at one locus that was significantly associated with the metabolic subtype. In a predictive model that was developed to classify a family-based cohort of 73 women with PCOS, subtypes were found to cluster in families. The likelihood of having the reproductive subtype was increased for carriers of rare variants in DENND1A.
“This is a very powerful objective approach to categorizing syndromes like PCOS into distinct subtypes with different causes, treatment, and clinical outcome,” a coauthor said in a statement.
One author disclosed financial ties to the biotechnology industry.
Gene Mutation Identified That Increases Lung Cancer Risk
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50
Family History of CRC Increases CRC Risk Similarly in IBD, General Population
Workplace Psychological Stress Linked to Erectile Function in Young Men
Adverse Pathological Features Do Not Predict Benefit of Hormone Therapy in Prostate Cancer
Body Fat Percentage May Be Better Indicator of Men"s Reproductive Health Than BMI
Early BPH Outcomes Comparable for p-ThuLEP and Open Prostatectomy
Aglatimagene Besadenovec + Valacyclovir Ups DFS in Localized Prostate Cancer